Dong Wha Pharma Co Ltd (000020):企業の財務・戦略的SWOT分析

◆英語タイトル:Dong Wha Pharma Co Ltd (000020) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH81874FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥84,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥126,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Dong Wha Pharma Co Ltd (Dongwha Pharm) is a pharmaceutical company that offers generic products. The company offers ethical drugs, over-the-counter products, cosmetics, health foods, medical devices, and food and drinks. Its products comprise clzapine tablets, valaboom, aripico tablets, intrinsic bubble cleanser, shampoos, tonic, danke cream and lotion. Dongwha Pharm provides muscle relaxants, antibiotics, dermatologicals, vitamins, anti-smoking agents, hepatic protectors, moega3 capsules, nutrients, tonics, cold remedies, mouth and teeth products and others. The company offers and drugs for alimentary system, cardiovascular and metabolic system, respiratory system, nervous system and urinary system. It operates in Incheon, Uiwang-si, Wonju-si, Dong-gu, Cheongju-si, and others. Dongwha Pharm is headquartered in Seoul, South Korea

Dong Wha Pharma Co Ltd Key Recent Developments

Apr 01,2021: Dong Wha Pharm signs an exclusive domestic license agreement for resistant hypertension treatment
Mar 15,2021: Dong Wha Pharm appoints Yoo Jun-ha as the new CEO
Jan 18,2021: Dong Wha Pharm launches Komakiten Nasal Spray, a rhinitis treatment
Nov 24,2020: COVID-19 treatment DW2008S Phase 2 clinical trial approved by the Ministry of Food and Drug Safety
Aug 19,2020: Dong Wha Pharm applies for a phase 2 clinical trial for COVID-19 treatment

This comprehensive SWOT profile of Dong Wha Pharma Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Dong Wha Pharma Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Dong Wha Pharma Co Ltd – Key Information
Dong Wha Pharma Co Ltd – Overview
Dong Wha Pharma Co Ltd – Key Employees
Dong Wha Pharma Co Ltd – Key Employee Biographies
Dong Wha Pharma Co Ltd – Key Operational Heads
Dong Wha Pharma Co Ltd – Major Products and Services
Dong Wha Pharma Co Ltd – History
Dong Wha Pharma Co Ltd – Company Statement
Dong Wha Pharma Co Ltd – Locations And Subsidiaries
Dong Wha Pharma Co Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Dong Wha Pharma Co Ltd – Business Description
Dong Wha Pharma Co Ltd – Corporate Strategy
Dong Wha Pharma Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Dong Wha Pharma Co Ltd – Strengths
Dong Wha Pharma Co Ltd – Weaknesses
Dong Wha Pharma Co Ltd – Opportunities
Dong Wha Pharma Co Ltd – Threats
Dong Wha Pharma Co Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Dong Wha Pharma Co Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Dong Wha Pharma Co Ltd, Key Information
Dong Wha Pharma Co Ltd, Key Ratios
Dong Wha Pharma Co Ltd, Share Data
Dong Wha Pharma Co Ltd, Major Products and Services
Dong Wha Pharma Co Ltd, History
Dong Wha Pharma Co Ltd, Key Employees
Dong Wha Pharma Co Ltd, Key Employee Biographies
Dong Wha Pharma Co Ltd, Key Operational Heads
Dong Wha Pharma Co Ltd, Other Locations
Dong Wha Pharma Co Ltd, Subsidiaries
Dong Wha Pharma Co Ltd, Key Competitors
Dong Wha Pharma Co Ltd, SWOT Analysis
Dong Wha Pharma Co Ltd, Ratios based on current share price
Dong Wha Pharma Co Ltd, Annual Ratios
Dong Wha Pharma Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Dong Wha Pharma Co Ltd (000020):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • QEP Resources, Inc.:企業の戦略・SWOT・財務分析
    QEP Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary QEP Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • NEC Corp (6701):電力:M&Aディール及び事業提携情報
    Summary NEC Corp (NEC) provides information technology and network technologies solutions. The company’s product portfolio includes servers, equipment and network systems for telecommunication carriers, supercomputers, personal computers, tablet terminals, automated teller machines, storage devices, …
  • Biocurv Medical Instruments, Inc.:企業の戦略・SWOT・財務情報
    Biocurv Medical Instruments, Inc. - Strategy, SWOT and Corporate Finance Report Summary Biocurv Medical Instruments, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Dairygold Co-operative Society Ltd:企業の戦略的SWOT分析
    Dairygold Co-operative Society Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Sompo Holdings Inc:企業の戦略・SWOT・財務分析
    Sompo Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Sompo Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cairn India Ltd (CAIRN)-石油・ガス分野:企業M&A・提携分析
    Summary Cairn India Limited (Cairn India) is an independent oil and gas company. It explores for, develops, and produces oil and natural gas. The company has varying working interests in India, Sri Lanka and South Africa. Its blocks are located in the basins of Barmer, Krishna- Godavari, the Palar-P …
  • CEZ, a. s.:企業の戦略・SWOT・財務分析
    CEZ, a. s. - Strategy, SWOT and Corporate Finance Report Summary CEZ, a. s. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Bulgarian Telecommunications Company (VIVACOM):企業の戦略的SWOT分析
    Bulgarian Telecommunications Company (VIVACOM) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitor …
  • Bangchak Corporation PCL (BCP):企業の財務・戦略的SWOT分析
    Bangchak Corporation PCL (BCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Dr. Reddy’s Laboratories Ltd (DRREDDY):企業の財務・戦略的SWOT分析
    Dr. Reddy's Laboratories Ltd (DRREDDY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Keane Group Inc (FRAC):石油・ガス:M&Aディール及び事業提携情報
    Summary Keane Group Inc (Keane Group) is an oil and gas company that offers integrated completion and drilling services. The company provides hydraulic fracturing services, engineered solutions, wire-line services, pressure pumping, cementing service, coiled tubing and well intervention services. It …
  • Axxam SpA-製薬・医療分野:企業M&A・提携分析
    Summary Axxam SpA (Axxam) is a partner research organization that provides drug discovery services. The organization offers drug discovery services such as molecular biology, assay development and reagent provision, compound management, hit characterization and profiling and electrophysiology, among …
  • LegoChem Biosciences Inc (141080):製薬・医療:M&Aディール及び事業提携情報
    Summary LegoChem Biosciences Inc (LCB) is a biopharmaceutical company that develops next generation novel therapeutics. The company utilizes its proprietary medicinal drug discovery technology LegoChemistry and ADC platform technology ConjuAll. It manufactures drugs in the therapeutic areas of antib …
  • Siemens Building Technologies:企業の戦略的SWOT分析
    Siemens Building Technologies - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • SIFCO Industries, Inc.:戦略・SWOT・企業財務分析
    SIFCO Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary SIFCO Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Domino’s Pizza, Inc.:企業の戦略・SWOT・財務分析
    Domino's Pizza, Inc. - Strategy, SWOT and Corporate Finance Report Summary Domino's Pizza, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Parexel International Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Parexel International Corp (Parexel) is a biopharmaceutical outsourcing service company which focuses on providing various services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers a comprehensive range of …
  • Slovnaft AS (1SLN01AE):企業の財務・戦略的SWOT分析
    Slovnaft AS (1SLN01AE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Bausch & Lomb Inc:企業の戦略的SWOT分析
    Bausch & Lomb Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • British Columbia Cancer Agency:製薬・医療:M&Aディール及び事業提携情報
    Summary British Columbia Cancer Agency (BC Cancer Agency), a subsidiary of Provincial Health Services Authority is a healthcare service center that provides comprehensive cancer control program. The center offers services such as diagnostic and therapy planning, radiation therapy, patient assessment …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆